PANKU-Lung01
What it tests: Izalontamab brengitecan in EGFR-mutant non-squamous NSCLC after progression on a third-generation EGFR TKI
The week in oncology, in your inbox
The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.